PropertyValue
?:definition
  • Molecular assay reagents intended for use in identifying deletions in chromosome 22 band q11.2. These genetic deletions are present in patients with an inherited autosomal dominant disorder characterized by congenital heart disease (in 3/4 of individuals), velopharyngeal incompetence, cleft palate, learning difficulties, and immunodeficiency.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
expand all